NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2019

Published	Pages	Publisher	Report code
Apr 2019	73	Global Markets Direct	ASDR-485662

Published: Apr 2019 - Pages : 73 - Publisher : Global Markets Direct - Report code : ASDR-485662

AnHeart Therapeutics Inc
Bayer AG
Chugai Pharmaceutical Co Ltd
F. Hoffmann-La Roche Ltd
Handok Inc

Published: November, 2019 | Report code: ASDR-497321

09 September - 10 September, 2024
London, United Kingdom